Review of current nonsurgical management of Peyronie's disease.
The current nonsurgical treatment options for men with Peyronie's disease is reviewed. The treatments currently employed and published in the English literature are discussed. A wide variety of nonsurgical treatment options are available to the practicing physician, including oral and topical medications, intralesional injection therapy, as well as employing external energy sources to drive medicine into the tunica albuginea by iontophoresis or direct stimulation of plaque change by shock wave therapy. Nonsurgical treatment of Peyronie's disease clearly has a place in the armamentarium of the practicing urologist. Oral therapy appears to have little therapeutic benefit. Injection and topical approaches deserve further attention. Yet, no single treatment stands out as the most effective remedy for all men with Peyronie's disease. Further controlled, large-scale studies are necessary to establish the benefits of these nonsurgical approaches. In the meantime, combination therapy appears to make sense in the nonsurgical treatment of men with Peyronie's disease.
Levine
L A
LA
Department of Urology, Rush Medical College, Chicago, Illinois, USA. drlevine@hotmail.com
D000975:Antioxidants / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D017364:Collagenases / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D010411:Penile Induration / Q000188:drug therapy*; D013256:Steroids / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000975:Antioxidants; D002121:Calcium Channel Blockers; D013256:Steroids; D014700:Verapamil; D017364:Collagenases; D003078:Colchicine